Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2024/03/02/2839130/26135/en/Adial-Pharmaceuticals-Announces-Exercise-of-Warrants-for-3-5-Million-Gross-Proceeds.html
https://www.globenewswire.com//news-release/2024/02/28/2837060/26135/en/Adial-Pharmaceuticals-Awarded-New-Patent-from-the-United-States-Patent-and-Trademark-Office.html
https://www.globenewswire.com//news-release/2024/02/13/2828348/26135/en/Adial-Pharmaceuticals-Awarded-New-Patent-Notice-of-Allowance-from-the-United-States-Patent-and-Trademark-Office.html
https://www.globenewswire.com//news-release/2024/01/18/2811538/26135/en/Adial-Announces-Appointment-of-Tony-Goodman-as-Chief-Operating-Officer.html
https://www.globenewswire.com//news-release/2023/12/20/2799294/26135/en/Adial-Pharmaceuticals-Receives-Final-Reimbursement-Payment-from-Adovate.html
https://www.globenewswire.com//news-release/2023/11/29/2788086/26135/en/Adial-Pharmaceuticals-Regains-Compliance-with-Nasdaq-Listing-Requirement.html
https://www.globenewswire.com//news-release/2023/11/14/2780605/26135/en/Adial-Pharmaceuticals-Reports-Third-Quarter-2023-Financial-Results-and-Provides-Business-Update.html
https://www.globenewswire.com//news-release/2023/10/31/2770186/26135/en/Adial-Pharmaceuticals-Chief-Medical-Officer-and-Key-Opinion-Leaders-to-Discuss-New-Aspects-in-Substance-Use-Treatment-at-The-Annual-International-Society-of-Addiction-Medicine-Conf.html
https://www.globenewswire.com//news-release/2023/10/25/2766447/26135/en/Addiction-Experts-Highlight-the-Need-for-Non-Abstinence-Based-Therapies-to-Treat-Alcohol-Use-Disorder-in-Adial-Pharmaceuticals-Key-Opinion-Leader-Webinar.html